$TELO SEC Filings

Filed On	Filing
27 Oct 2026	S-3
06 Oct 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of Otocber 5, 2026, by and among Telomir Pharmaceuticals, Inc., a Florida corporation (the “Company”), and each of the entities listed on Exhibit A attached to this Agreem...
17 Sep 2026	8-K: Regulation FD Disclosure Telomir Announces Peer-Reviewed Publication Showing Telomir-Zn Restores Visual Function and Retinal Structure in a Model of Age-Related Macular Degeneration (AMD)
16 Sep 2026	8-K: Submission of Matters to a Vote of Security Holders On September 11, 2026, Telomir Pharmaceuticals, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). The record date for stockholders entitled to notice of and to vote at the Annual Meeting was July 2...
14 Sep 2026	8-K: Regulation FD Disclosure Telomir Announces Research with The Ohio State University Demonstrating In-Vitro Anti-Cancer Activity in Human and Canine Osteosarcoma Models
19 Aug 2026	DEFA14A
14 Aug 2026	SCHEDULE 13G/A
13 Aug 2026	10-Q
10 Aug 2026	8-K: Regulation FD Disclosure
28 Jul 2026	Proxy statement: annual meeting
27 Jul 2026	Form 4: Whalen Matthew Pratt, Director Granted 50,000 Non-Qualified Stock Options (right to buy)
27 Jul 2026	Form 4: MacPherson Edward Clouston, Director Granted 50,000 Non-Qualified Stock Options (right to buy)
27 Jul 2026	Form 4: Del Giudice Matthew Paul, Director Granted 50,000 Non-Qualified Stock Options (right to buy)
15 Jun 2026	8-K: Regulation FD Disclosure
09 Jun 2026	Form 3: Mushak Andriy, Chief Financial Officer No securities owned
08 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation
22 May 2026	Form 4: Aminov Erez, Director Granted 1,960,170 Incentive Stock Options (right to buy) · Disposed of 1,960,170 Incentive Stock Options (right to buy) (Disposition to Issuer) · Granted 2,000,000 Non-Qualified Stock Options (right to buy) · 1 more
22 May 2026	Form 4: Whalen Matthew Pratt, Director Granted 25,000 Incentive Stock Options (right to buy) · Disposed of 25,000 Incentive Stock Options (right to buy) (Disposition to Issuer)
22 May 2026	Form 4: MacPherson Edward Clouston, Director Granted 25,000 Incentive Stock Options (right to buy) · Disposed of 25,000 Incentive Stock Options (right to buy) (Disposition to Issuer)
22 May 2026	Form 4: Del Giudice Matthew Paul, Director Granted 25,000 Incentive Stock Options (right to buy) · Disposed of 25,000 Incentive Stock Options (right to buy) (Disposition to Issuer)

Comments